Bayer Financial Statements From 2010 to 2024

BAYRYDelisted Stock  USD 16.86  0.86  5.37%   
Bayer AG financial statements provide useful quarterly and yearly information to potential Bayer AG PK investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bayer AG financial statements helps investors assess Bayer AG's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bayer AG's valuation are summarized below:
Bayer AG PK does not presently have any fundamental signals for analysis.
Check Bayer AG financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bayer main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Bayer financial statements analysis is a perfect complement when working with Bayer AG Valuation or Volatility modules.
  
This module can also supplement various Bayer AG Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Bayer Return On Asset Analysis

Bayer AG's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Bayer AG Return On Asset

    
  0.0576  
Most of Bayer AG's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayer AG PK is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Bayer AG PK has a Return On Asset of 0.0576. This is 100.66% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 141.14% lower than that of the firm.

Bayer AG PK Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bayer AG's current stock value. Our valuation model uses many indicators to compare Bayer AG value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bayer AG competition to find correlations between indicators driving Bayer AG's intrinsic value. More Info.
Bayer AG PK is number one stock in current ratio category among related companies. It is number one stock in current liabilities category among related companies creating about  14,376,724,138  of Current Liabilities per Current Ratio. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bayer AG by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bayer AG's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bayer AG's earnings, one of the primary drivers of an investment's value.

About Bayer AG Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bayer AG income statement, its balance sheet, and the statement of cash flows. Bayer AG investors use historical funamental indicators, such as Bayer AG's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bayer AG investors may use each financial statement separately, they are all related. The changes in Bayer AG's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bayer AG's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bayer AG Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bayer AG. Please read more on our technical analysis and fundamental analysis pages.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on OTC Exchange in the United States.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bayer AG in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bayer AG's short interest history, or implied volatility extrapolated from Bayer AG options trading.

Pair Trading with Bayer AG

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bayer AG position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer AG will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bayer Pink Sheet

  0.73MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr

Moving against Bayer Pink Sheet

  0.84KA Kineta Inc Report 29th of March 2024 PairCorr
  0.59MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.54MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.44VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Bayer AG could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bayer AG when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bayer AG - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bayer AG PK to buy it.
The correlation of Bayer AG is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bayer AG moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bayer AG PK moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bayer AG can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Bayer Pink Sheet

If you are still planning to invest in Bayer AG PK check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bayer AG's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets